Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8297
Reference
MSAN(2024)60
Name
Trandate® (labetalol) 50mg tablets
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Department
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Trandate® (labetalol) 50mg tablets will be discontinued from July 2025.
Alternative low dose beta-blockers remain available. Where these are not suitable, UK manufactured specials of labetalol 50mg/5ml oral suspension may be sourced, lead times vary.
Contact Name
Contact Email
Contact Address
Created
2024-10-16 09:55:00
Click to go back to homepage